Under one of the S&P 500 eligibility criteria that remains unchanged, a company must report profits under Generally Accepted ...

The Allspring Asset Allocation Fund outperformed its benchmark in Q1 2026 despite market volatility. Read the full analysis ...

ExploreDVI ETF: tech-focused dividend target income with AI upside, 6.4% yield, and options strategy—see risks, returns & fit ...

May, but it has since begun to follow the oil price downward and last week generated evidence of an intermediate-term top ...

UnitedHealth (UNH) is re-rated to Hold after a sharp rally and valuation expansion post-FQ1 2026. Read here for a detailed ...

Edgewise Therapeutics (EWTX) stays a Buy after its $2.65B Servier deal funds EDG-7500 for HCM with key Q2 2026 data. Read ...

Chevron upgraded to Strong Buy: robust production growth, limited Middle East risk, solid Q1 results, and undervalued shares ...

RV sales, backlog, and margins fell; cash flow turned negative, and EPS guidance was cut. Read here for an analysis of THO ...

Truist Financial (TFC) outlook: buybacks, surplus capital, and a 4%+ dividend support EPS growth. Read here for a detailed ...

Replimune (REPL) faces a binary FDA decision on RP1 in advanced melanoma. RP1 approval could push REPL to $14.99/share. See ...

President Trump announced plans to direct ‌hundreds of millions of dollars to support US coal-fired power plants and coal ...

The Russell 2000 has outperformed the S&P 500 YTD, and earnings are expected to soar in 2026. Discover 5 top Russell 2000 ...